TEX markers were not detected in their small cohort of healthy controls (n = 5), whilst in the cancer patients, the TEX/Total exosome ratio, as well as total exosomal protein levels, were significantly different in patients who had recurrence after treatment. This evidence concerns the gene TEX46 and cancer.